Lethal Genetic Diseases
Lethal genetic diseases are caused by mutations in essential genes that can lead to the death of the affected organism. These mutations often disrupt critical processes required for development or growth. Lethal alleles can be classified as recessive, dominant, or conditional, depending on their genetic behaviour. They may cause death either before or shortly after birth, but typically manifest early in development.
Key Examples of Lethal Genetic Diseases:
Cystic Fibrosis
Sickle-Cell Anaemia
Achondroplasia
Related Conference of Lethal Genetic Diseases
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Lethal Genetic Diseases Conference Speakers
Recommended Sessions
- Biochemical Genetics
- Cancer Genetics
- Classical Genetics
- Clinical Genetics
- Common Genetic Diseases
- Comparative Genomics
- Gene Function Prediction & Genome Annotation
- Gene Therapy
- Genetic Counselling
- Genetic Epidemiology
- Genetic Medicine
- Genetics of Cardiovascular Diseases
- Genome Integrity
- Immunogenetics
- Lethal Genetic Diseases
- Neurogenetics
- Nutrigenics and Nutrigenomics
- Pharmacogenomics
- Phylogenetic
- Population Genetics
- Yoga Practise and Genetic Changes
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
